Vivus, Why the Slide? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus, Why the Slide?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Hua who wrote (1986)	6/15/1997 9:16:00 PM
From: Edderd	of 3991

Tom, My guess on the last quarter is that the new peoduction facility will be inproduction early. The request to the FDA to reinspect may include some preliminary inspections on the new facility (they are both in NJ and I understand close to each other. That might indicate that the new facility is close to operational. That will certainly boost Q4. I still hears from patients that say their pharmacies are out of a certain dose (usually 500 ugm) and backordered so the demand is still there. If you calculate 9000 urologists ordering 3/week thats 27000/wk but our group (7urologists) averages 10/day. Being in FL may make a difference but there are older folks everywhere. The market is in the older population and has been barely touched. What happens two years from now is of remote interest. The intermediate Q's earnings probably reflect the cost of the new facilities. Maybe they didn't borrow any money! That would be interesting. Keep in touch. Ed

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next